Welcome to
EU-China Vaccine Collaboration Forum 2023
Since the introduction of mRNA vaccines in September 2021, global biotechnology has exploded, with synthetic biology, preventive vaccines, therapeutic vaccines and mRNA drugs ushering in a "golden decade", and Europe and the United States have made significant progress in key delivery systems, sequence optimisation and production processes, while a large number of emerging biotechnology enterprises have emerged in China. Now is the best time for China and Europe to carry out exchanges and cooperation.
2023 China-EU Vaccine Industry International Cooperation Forum will invite more than 20 top European research institutes to focus on the latest technologies in the world, such as mRNA, adjuvant, protein labelling, liposome nano-delivery, high throughput sequencing, drug coupler, and anti-microbial resistance ,etc. The forum will share R&D results, explore synergistic innovation, discuss investment and cooperation, and provide a new global vision for the international synergistic development of the vaccine industry.
